BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 17452940)

  • 1. Mechanisms of sepsis-induced cardiac dysfunction.
    Rudiger A; Singer M
    Crit Care Med; 2007 Jun; 35(6):1599-608. PubMed ID: 17452940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy.
    De Kock I; Van Daele C; Poelaert J
    Acta Clin Belg; 2010; 65(5):323-9. PubMed ID: 21128559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myocardial dysfunction in sepsis--definition and pathogenetic mechanisms].
    Muriová K; Maláska J; Otevrel F; Slezák M; Kratochvíl M; Sevík P
    Vnitr Lek; 2010 Mar; 56(3):220-5. PubMed ID: 20394208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Mechanisms in Septic Cardiomyopathy.
    Cimolai MC; Alvarez S; Bode C; Bugger H
    Int J Mol Sci; 2015 Aug; 16(8):17763-78. PubMed ID: 26247933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial dysfunction in the patient with sepsis.
    Krishnagopalan S; Kumar A; Parrillo JE; Kumar A
    Curr Opin Crit Care; 2002 Oct; 8(5):376-88. PubMed ID: 12357104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myocardial dysfunction during sepsis: epidemiology, prognosis and treatment].
    Paoli G; Valente S; Ardissino D; Gensini GF
    G Ital Cardiol (Rome); 2011 Dec; 12(12):804-14. PubMed ID: 22158451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathomechanisms of myocardial dysfunction in sepsis.
    Lorigados CB; Soriano FG; Szabo C
    Endocr Metab Immune Disord Drug Targets; 2010 Sep; 10(3):274-84. PubMed ID: 20509838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Serum sTREM-1 Correlates With Myocardial Dysfunction and Predicts Prognosis in Septic Patients.
    Li Z; Zhang E; Hu Y; Liu Y; Chen B
    Am J Med Sci; 2016 Jun; 351(6):555-62. PubMed ID: 27238916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms.
    Flynn A; Chokkalingam Mani B; Mather PJ
    Heart Fail Rev; 2010 Nov; 15(6):605-11. PubMed ID: 20571889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mitochondria in sepsis-induced cardiomyopathy.
    Stanzani G; Duchen MR; Singer M
    Biochim Biophys Acta Mol Basis Dis; 2019 Apr; 1865(4):759-773. PubMed ID: 30342158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy.
    Pan P; Wang X; Liu D
    J Int Med Res; 2018 Jun; 46(6):2157-2169. PubMed ID: 29637807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heart in sepsis: from basic mechanisms to clinical management.
    Rudiger A; Singer M
    Curr Vasc Pharmacol; 2013 Mar; 11(2):187-95. PubMed ID: 23506497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKCδ causes sepsis-induced cardiomyopathy by inducing mitochondrial dysfunction.
    Joseph LC; Reyes MV; Lakkadi KR; Gowen BH; Hasko G; Drosatos K; Morrow JP
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H778-H786. PubMed ID: 32142354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy].
    Martin L; Derwall M; Thiemermann C; Schürholz T
    Anaesthesist; 2017 Jul; 66(7):479-490. PubMed ID: 28677016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical review: Myocardial depression in sepsis and septic shock.
    Court O; Kumar A; Parrillo JE; Kumar A
    Crit Care; 2002 Dec; 6(6):500-8. PubMed ID: 12493071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-Derived Neurotrophic Factor Attenuates Septic Myocardial Dysfunction via eNOS/NO Pathway in Rats.
    Zeng N; Xu J; Yao W; Li S; Ruan W; Xiao F
    Oxid Med Cell Longev; 2017; 2017():1721434. PubMed ID: 28770018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of cardiomyocyte S-nitrosylation by S-nitrosoglutathione reductase protects against sepsis-induced myocardial depression.
    Sips PY; Irie T; Zou L; Shinozaki S; Sakai M; Shimizu N; Nguyen R; Stamler JS; Chao W; Kaneki M; Ichinose F
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1134-46. PubMed ID: 23417863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Septic cardiomyopathy: pathophysiology and potential new therapeutic approaches].
    Suzuki T; Sakai M; Yamashita S; Tomita K; Hattori Y
    Nihon Yakurigaku Zasshi; 2018; 151(3):111-116. PubMed ID: 29526919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-induced nitric oxide inhibits mitochondrial energy production and induces myocardial dysfunction in endotoxin-treated rat hearts.
    Tatsumi T; Akashi K; Keira N; Matoba S; Mano A; Shiraishi J; Yamanaka S; Kobara M; Hibino N; Hosokawa S; Asayama J; Fushiki S; Fliss H; Nakagawa M; Matsubara H
    J Mol Cell Cardiol; 2004 Sep; 37(3):775-84. PubMed ID: 15350850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic contribution of melatonin to the treatment of septic cardiomyopathy: A novel mechanism linking Ripk3-modified mitochondrial performance and endoplasmic reticulum function.
    Zhong J; Tan Y; Lu J; Liu J; Xiao X; Zhu P; Chen S; Zheng S; Chen Y; Hu Y; Guo Z
    Redox Biol; 2019 Sep; 26():101287. PubMed ID: 31386965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.